KK

Karthik Kiran Mysor Umashankar

Active Director Director DIN 11347985
DIN 11347985 First appointment Oct 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Karthik Kiran Mysor Umashankar

Data last updated:

Karthik Kiran Mysor Umashankar is a Director at Shree Neel Meditech Private Limited (since 2025).

DIN 11347985
Primary Designation Director
First Appointment 18 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shree Neel Meditech Private Limited U46497KA2025PTC209910
Director18 Oct 20252025Active

Board colleagues of Karthik Kiran Mysor Umashankar

NameDINCompanyDesignation
Sathyanarayana Srinivas11347986Shree Neel Meditech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shree Neel Meditech Private Limited
Premium access

Shareholding and investment profile for Karthik Kiran Mysor Umashankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karthik Kiran Mysor Umashankar

Karthik Kiran Mysor Umashankar currently holds 1 directorship: Shree Neel Meditech Private Limited (Director, since 18 Oct 2025).

Karthik Kiran Mysor Umashankar was first appointed on 18 Oct 2025 as Director at Shree Neel Meditech Private Limited.

The current boards of Karthik Kiran Mysor Umashankar's companies include Sathyanarayana Srinivas (Shree Neel Meditech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available